3,4-Pyrrolidinediol,2-(hydroxymethyl)

热门搜索化学品最多只显示前20条，请点击“搜索化学品”查看所有结果

CAS登录号

中文名

英文名

分子结构式

分子式

详情

供应商

100937-52-8

1,4-二脱氧-1,4-亚氨基-D-阿拉伯糖醇;
2-羟甲基-3,4-吡咯烷二醇

3,4-Pyrrolidinediol,2-(hydroxymethyl)-, (2R,3R,4R)-;
3,4-Pyrrolidinediol,2-(hydroxymethyl)-, [2R-(2a,3b,4a)]-;
(2R,3R,4R)-3,4-Dihydroxy-2-(hydroxymethyl)pyrrolidine;
1,4-Dideoxy-1,4-imino-D-arabinitol;
DAB 1

3,4-Pyrrolidinediol,2-(hydroxymethyl)-1-methyl-, (2R,3R,4S)-;
3,4-Pyrrolidinediol,2-(hydroxymethyl)-1-methyl-, [2R-(2a,3b,4b)]-

3,4-Pyrrolidinediol,2-(hydroxymethyl)-1-methyl-;
3,4-Pyrrolidinediol,2-(hydroxymethyl)-1-methyl-(9CI)

3,4-Pyrrolidinediol,2-(hydroxymethyl)-1-(phenylmethyl)-, (2S,3S,4R)-;
3,4-Pyrrolidinediol,2-(hydroxymethyl)-1-(phenylmethyl)-, [2S-(2a,3b,4b)]-;
N-Benzyl-1,4-dideoxy-1,4-imino-L-ribitol

3,4-Pyrrolidinediol,2-(hydroxymethyl)-1-methyl-, (2R,3R,4R)-;
3,4-Pyrrolidinediol,2-(hydroxymethyl)-1-methyl-, [2R-(2a,3b,4a)]-;
N-Methyl-1,4-dideoxy-1,4-imino-D-arabinitol

3,4-Pyrrolidinediol,2-(hydroxymethyl)-, (2S,3S,4S)-;
3,4-Pyrrolidinediol,2-(hydroxymethyl)-, [2S-(2a,3b,4a)]-;
1,4-Dideoxy-1,4-imino-L-arabinitol

3,4-Pyrrolidinediol,2-(hydroxymethyl)-, hydrochloride (1:1), (2S,3S,4R)-;
3,4-Pyrrolidinediol,2-(hydroxymethyl)-, hydrochloride, (2S,3S,4R)- (9CI);
3,4-Pyrrolidinediol,2-(hydroxymethyl)-, hydrochloride, [2S-(2a,3b,4b)]-

3,4-Pyrrolidinediol,2-(hydroxymethyl)-1-(2,2,2-trifluoroethyl)-, (2R,3R,4R)-;
3,4-Pyrrolidinediol,2-(hydroxymethyl)-1-(2,2,2-trifluoroethyl)-, [2R-(2a,3b,4a)]-

3,4-Pyrrolidinediol,2-(hydroxymethyl)-5-(4-nitrophenyl)-, (2R,3R,4S,5S)-;
3,4-Pyrrolidinediol,2-(hydroxymethyl)-5-(4-nitrophenyl)-, [2R-(2a,3b,4b,5a)]-

3,4-Pyrrolidinediol,2-(hydroxymethyl)-5-(3-nitrophenyl)-, (2R,3R,4S,5S)-;
3,4-Pyrrolidinediol,2-(hydroxymethyl)-5-(3-nitrophenyl)-, [2R-(2a,3b,4b,5a)]-

3,4-Pyrrolidinediol,2-(hydroxymethyl)-5-(3-pyridinyl)-, (2R,3R,4S,5S)-;
3,4-Pyrrolidinediol,2-(hydroxymethyl)-5-(3-pyridinyl)-, [2R-(2a,3b,4b,5a)]-

3,4-Pyrrolidinediol,2-(hydroxymethyl)-5-(4-hydroxyphenyl)-, (2R,3R,4S,5S)-;
3,4-Pyrrolidinediol,2-(hydroxymethyl)-5-(4-hydroxyphenyl)-, [2R-(2a,3b,4b,5a)]-

3,4-Pyrrolidinediol,2-(hydroxymethyl)-, (2R,3R,4S)-rel-;
3,4-Pyrrolidinediol,2-(hydroxymethyl)-, (2a,3b,4b)-;
DL-Ribitol, 1,4-dideoxy-1,4-imino-

3,4-Pyrrolidinediol,2-(hydroxymethyl)-5-(2-thienyl)-, [2R-(2a,3b,4b,5a)]- (9CI);
3,4-Pyrrolidinediol,2-(hydroxymethyl)-5-(2-thienyl)-,[2R-(2alpha,3bta,4bta,5alpha)]-(9CI);
3,4-Pyrrolidinediol, 2-(hydroxymethyl)-5-(2-thienyl)-, [2R-(2alpha,3ba,4ba,5alpha)]- (9CI)

3,4-Pyrrolidinediol,2-(hydroxymethyl)-5-(9H-purin-9-ylmethyl)-, (2R,3R,4S,5S)-;
3,4-Pyrrolidinediol, 2-(hydroxymethyl)-5-(9H-purin-9-ylmethyl)-, (2R,3R,4S,5S)-

3,4-Pyrrolidinediol,2-(hydroxymethyl)-5-(2-thienyl)-, (2R,3R,4S,5S)-;
3,4-Pyrrolidinediol, 2-(hydroxymethyl)-5-(2-thienyl)-, (2R,3R,4S,5S)- (9CI)

3,4-Pyrrolidinediol,2-(hydroxymethyl)-, hydrochloride (1:1), (2S,3S,4S)-;
3,4-Pyrrolidinediol,2-(hydroxymethyl)-, hydrochloride, (2S,3S,4S)- (9CI);
3,4-Pyrrolidinediol,2-(hydroxymethyl)-, hydrochloride, [2S-(2a,3b,4a)]-